Take Control of Your Psoriasis.

Find Freedom with Zerigo Health.

$0
per month1

Psoriasis is a chronic autoimmune disease that causes skin cells to grow too quickly, resulting in thick, scaly patches. These patches can leave psoriasis sufferers with ongoing symptoms including  itching, pain, and embarrassment. While there's no cure, various treatments can help manage symptoms and improve quality of life.

Phototherapy, including narrowband UVB (NB-UVB) light therapy, is a common treatment option for psoriasis. NB-UVB light slows down skin cell growth and reduces inflammation. It is a safe and effective treatment for many people with psoriasis.

Other treatment options for psoriasis include:

  • Topical medications: Creams and ointments to reduce inflammation and slow skin cell growth.
  • Systemic medications: Oral or injected medications to target the immune system.
  • Biologics & biosimilars: Targeted therapies that suppress specific parts of the immune system.
AdobeStock_561373661

Zerigo’s Skin Health Program for Psoriasis

The Zerigo Skin Health Program is reinventing treatment for people with chronic skin conditions like psoriasis by harnessing the proven power of narrowband UVB phototherapy in a portable, handheld device1 backed by a holistic care program—at no cost to you1.

treatment-icon

Convenient Care

Free yourself from the pain and disruption of living with psoriasis. The Zerigo Skin Health Program makes treatment painless, hassle-free, and convenient from anywhere, at any time that works for you.

convinient-icon

Tailored Treatment

Your skin condition is unique to you. That’s why every Zerigo treatment plan is tailored to meet you where you are today and get you on the road to clearer skin—fast.

employee-satisfaction-icon

Proven Results

Break the trial-and-error treatment cycle. Used as a standalone treatment or in combination with advanced therapies, narrowband UVB phototherapy is a proven approach2 to deliver maximum clearance without the side effects.

Why should you consider using the Zerigo Skin Health Program to treat your psoriasis?

  • More than 25 years of clinical data2 support NB-UVB as one of the most effective treatments for psoriasis, atopic dermatitis, and vitiligo
  • Light therapy improves skin by calming overactive immune cells, decreasing inflammation, and promoting normal skin barrier growth3
  • Light therapy produces minimal side-effects and immune system suppression
  • In a 2021 study, 94% of patients with psoriasis achieve clearance in 30 phototherapy treatments7
  • Zerigo Health has a 4.9/5 member satisfaction rating
  • More than 95% of our patients say Zerigo’s Skin Health Program is easy to use8
  • People with psoriasis are more likely to follow Zerigo’s treatment program than those who inject biologics or take pills.10

Don’t Take Our Word for It

Zerigo members can’t stop talking about their results.

Love the [Zerigo] system…I began noticing results within 6 weeks and it completely healed around the 3-month mark. I can finally leave my house embarrassment-free and make-up free again.
Love how the app tells me when it’s time to treat!
Clear skin without psoriasis? It’s the best!
It’s been one of the only things that has helped clear my psoriasis. I’m so happy that I finally found something that works for me!
It’s been one of the only things that has helped clear my psoriasis. I’m so happy that I finally found something that works for me.
Great product and service. I can do my treatment on my own time and no need to go to a clinic. My Care Guide is very responsive and helpful, always in contact and doing follow-up with me. Thank you!

References & Disclaimers

1The Zerigo Health Phototherapy System is an ultraviolet-light-emitting medical device. It is intended for use in localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma on all skin types (I-VI). The device can be used in the comfort of a patient’s home or in a physician’s office. Individual results may vary. U.S. federal law restricts this device to sale by or on the order of a physician.

2See, e.g., Elmets CA, et al., Joint American Academy of Dermatology: National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy, 2019 Sep;81(3):775-804; Myers E, Kheradmand S, Miller R. An Update on Narrowband Ultraviolet B Therapy for the Treatment of Skin Diseases. Cureus. 2021 Nov 1;13(11):e19182.

3Springer Dermatological Research; Adjunctive Treatment of Atopic Dermatitis with Novel At-Home Handheld Narrow-Band UVB Phototherapy

4The Zerigo Health Solution is available through your healthcare benefits as a value-added service. You may have to pay a copay or coinsurance if you see your doctor to get a prescription for phototherapy treatment.

5Zerigo Care Guides include RNs, MAs, and certified health and wellness coaches who can help coordinate and facilitate your discussion with your doctor. The Care Guides do not prescribe therapies or provide patient-specific medical advice. For questions about your prescription or treatment plan, please contact your doctor.

6Offered in conjunction with independent virtual care provider, CirrusMD.

7Cutis, Phototherapy: Safe and Effective for Chronic skin conditions in older adults

8Zerigo Health member survey, conducted May 2020

9Springer Dermatological Research; Adjunctive Treatment of Atopic Dermatitis with Novel At-Home Handheld Narrow-Band UVB Phototherapy 

10Journal of Dermatological Treatment; Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies

11Journal of Drugs in Dermatology; The Impact of At-Home Narrow-Band UVB Phototherapy for Mild-to-Severe Psoriasis 

12Based on third party actuarial data on chronic skin condition advanced therapy costs among 30 million commercial plan members

13Estimated average return on investment (ROI) for commercial member with psoriasis. In analysis of claims cost of 30 million commercial health plan members, projected ROI vary from 3x-15x depending on diagnosis and advanced therapies used.

14One year pilot with large national PBM conducted with commercial health plan members

15CirrusMD website 

16Danesh et al, 2015 and Anderson et al, 2015

17Journal of Managed Care & Specialty Pharmacy, The Direct and Indirect Costs of Atopic Dermatitis

18National Institutes of Health, Burden of Atopic Dermatitis in Adults and Adolescents

19PLOS One, Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011

1A copay or co-insurance may be required when you see a physician to request a prescription for phototherapy treatment. 2The Zerigo System received FDA clearance on May 23, 2017. The Zerigo Health Phototherapy System is an Ultraviolet Light Emitting Medical Device. It is intended for use in localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis and leukoderma on all skin types (I-VI). The Zerigo Health Solution is not intended to provide medical advice or be a substitution for appropriate or necessary health care treatment. 3Individual results with the Zerigo System may vary depending on many factors, including the severity of eczema or psoriasis and completion of the prescribed treatment program. 4Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy. The American Academy of Dermatology guidelines of care for the management of atopic dermatitis.